|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei
WQ, Qiao YL and Inoue M: Comparative epidemiology of gastric cancer
between Japan and China. World J Gastroenterol. 17:4421–4428. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Waddell T, Chau I, Cunningham D, Gonzalez
D, Okines AF, Okines C, Wotherspoon A, Saffery C, Middleton G,
Wadsley J, et al: Epirubicin, oxaliplatin and capecitabine with or
without panitumumab for patients with previously untreated advanced
oesophagogastric cancer (REAL3): A randomised, open-label phase 3
trial. Lancet Oncol. 14:481–489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smalley SR, Benedetti JK, Haller DG,
Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson
JA, Jessup JM, et al: Updated analysis of SWOG-directed intergroup
study 0116: A phase III trial of adjuvant radiochemotherapy versus
observation after curative gastric cancer resection. J Clin Oncol.
30:2327–2333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coburn NG, Lourenco LG, Rossi SE, Gunraj
N, Mahar AL, Helyer LK, Law C, Rabeneck L and Paszat L: Management
of gastric cancer in Ontario. J Surg Oncol. 102:54–63. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roy M, Reddy PH, Iijima M and Sesaki H:
Mitochondrial division and fusion in metabolism. Curr Opin Cell
Biol. 33:111–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Y, Butler EB and Tan M: Targeting
cellular metabolism to improve cancer therapeutics. Cell Death Dis.
4:e5322013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boland ML, Chourasia AH and Macleod KF:
Mitochondrial dysfunction in cancer. Front Oncol. 3:2922013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ubah OC and Wallace HM: Cancer therapy:
Targeting mitochondria and other sub-cellular organelles. Curr
Pharm Des. 20:201–222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bossy-Wetzel E, Barsoum MJ, Godzik A,
Schwarzenbacher R and Lipton SA: Mitochondrial fission in
apoptosis, neurodegeneration and aging. Curr Opin Cell Biol.
15:706–716. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Imai Y and Lu B: Mitochondrial dynamics
and mitophagy in Parkinson's disease: Disordered cellular power
plant becomes a big deal in a major movement disorder. Curr Opin
Neurobiol. 21:935–941. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang CR and Blackstone C: Dynamic
regulation of mitochondrial fission through modification of the
dynamin-related protein Drp1. Ann N Y Acad Sci. 1201:34–39. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cronin-Furman EN, Borland MK, Bergquist
KE, Bennett JP Jr and Trimmer PA: Mitochondrial quality, dynamics
and functional capacity in Parkinson's disease cybrid cell lines
selected for Lewy body expression. Mol Neurodegener. 8:62013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Archer SL: Mitochondrial
dynamics-mitochondrial fission and fusion in human diseases. N Engl
J Med. 369:2236–2251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mishra P and Chan DC: Mitochondrial
dynamics and inheritance during cell division, development and
disease. Nat Rev Mol Cell Biol. 15:634–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frank S, Gaume B, Bergmann-Leitner ES,
Leitner WW, Robert EG, Catez F, Smith CL and Youle RJ: The role of
dynamin-related protein 1, a mediator of mitochondrial fission, in
apoptosis. Dev Cell. 1:515–525. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tailor D, Hahm ER, Kale RK, Singh SV and
Singh RP: Sodium butyrate induces DRP1-mediated mitochondrial
fusion and apoptosis in human colorectal cancer cells.
Mitochondrion. 16:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park SJ, Park YJ, Shin JH, Kim ES, Hwang
JJ, Jin DH, Kim JC and Cho DH: A receptor tyrosine kinase
inhibitor, Tyrphostin A9 induces cancer cell death through Drp1
dependent mitochondria fragmentation. Biochem Biophys Res Commun.
408:465–470. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
DuBoff B, Gotz J and Feany MB: Tau
promotes neurodegeneration via DRP1 mislocalization in vivo.
Neuron. 75:618–632. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan J, Liu XH, Han MZ, Wang YM, Sun XL, Yu
N, Li T, Su B and Chen ZY: Blockage of GSK3beta-mediated Drp1
phosphorylation provides neuroprotection in neuronal and mouse
models of Alzheimer's disease. Neurobiol Aging. 36:211–227. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Inoue-Yamauchi A and Oda H: Depletion of
mitochondrial fission factor DRP1 causes increased apoptosis in
human colon cancer cells. Biochem Biophys Res Commun. 421:81–85.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferreira-da-Silva A, Valacca C, Rios E,
Populo H, Soares P, Sobrinho-Simões M, Scorrano L, Maximo V and
Campello S: Mitochondrial dynamics protein Drp1 is overexpressed in
oncocytic thyroid tumors and regulates cancer cell migration. PLoS
One. 10:e01223082015. View Article : Google Scholar : PubMed/NCBI
|
